Aug 28, 2026
Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough
Moderna (MRNA) stock fell 4.6% Friday despite breakthrough cancer vaccine results. Analysts project $3B sales by 2035. Price targets range $74-$135.
The post Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough appeared first on Blockonomi.
Source: Blockonomi →Related News
- 9 hours ago
Paramount Settlement Sends WBD Stock Sharply Higher
- 9 hours ago
NFLX Stock Drops After Wells Fargo Warning
- 9 hours ago
NBIS Stock Jumps 5.6% as AI Pricing Boosts Momentum
- 10 hours ago
T-Mobile US (TMUS) Stock: New Jio Partnership Advances Global 5G Roaming
- 10 hours ago
Semtech Corporation (SMTC) Stock: New 50G Technology Supports 6G Transition